Cancer research training: the Southwest Oncology Group young investigator training program (YITP)

Zeina Nahleh1, Rami Komrokji, Abdul-Rahman Jazieh

  • 1Department of Internal Medicine, Division of Hematology-Oncology, University of Cincinnati, USA. nalehza@ucmail.uc.edu

Abstract

Insights

The Southwest Oncology Group (SWOG) Young Investigator Training Program (YITP) trains new cancer researchers in clinical trial development. This program has successfully trained 31 investigators and activated 15 clinical protocols.

Area of Science:

  • Oncology
  • Clinical Trials
  • Medical Education

Background:

  • Addressing a decline in trained cancer researchers.
  • Southwest Oncology Group (SWOG) established the Young Investigator Training Program (YITP) in 1999.
  • The Hope Foundation provides financial support for the YITP.

Purpose of the Study:

  • To describe the SWOG Young Investigator Training Program (YITP).
  • To evaluate the program's impact on training new cancer researchers.
  • To encourage continued support for similar initiatives.

Main Methods:

  • Rigorous selection of four Hematology-Oncology physicians annually.
  • Intensive training in statistical principles, data collection, analysis, and protocol development.
  • Hands-on experience designing clinical protocols within SWOG.

Main Results:

  • 31 investigators trained by the class of 2004.
  • 15 clinical protocols introduced and activated across the U.S.
  • Four additional protocols are in development and approval stages.

Conclusions:

  • The SWOG YITP offers a unique opportunity to learn cancer clinical trial conduct.
  • The program successfully builds an infrastructure of skilled cancer researchers.
  • Continued sponsorship of similar programs is crucial for advancing cancer research.

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...